Janus Global Life Sciences U GBP Inc (FUND:BRJ9D74) - Overview

Fund Report

Janus Capital Funds plc - Global Life Sciences Fund U GBP Inc

Key Stats
Morningstar® CategorySector Equity Healthcare
Manager NameAndrew Acker
Inception Date20/10/2014
NAV 06/12/2016GBP 13.80
Day Change0.66%
12 Month Yield0.00%
ISINIE00BRJ9D748
SEDOLBRJ9D74
Dividend FrequencyMonthly
Net Assets (mil) 30/09/20161,558.89 USD
Wrapper AvailabilityAll
Our Minimum Initial Investment2,500.00 GBP
Pricing FrequencyDaily
Dealing Cut off Time20:00:00
Regular InvestmentNo
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Fund Ongoing Charge0.99%
AMC0.80%
Fund Rebate-

Morningstar Rating™

Not Rated

Morningstar Sustainability Rating

Below Average

Below Average


Sustainability Rating as of 30/09/2016

Benchmarks

Fund Benchmark

MSCI World/Health Care NR USD

Morningstar® Benchmark

MSCI World/Health Care NR USD

Growth Of 10,000 (GBP) 30/11/2016

How has this security performed
20122013201420152016
Fund---13.394.33
Category---11.406.35
Benchmark---12.778.23
  • Fund: Janus Capital Funds plc - Global Life Sciences Fund U GBP Inc
  • Category: Sector Equity Healthcare
  • Benchmark: MSCI World/Health Care NR USD
Trailing Returns % (GBP) 06/12/2016
FundCatBmark
YTD3.143.066.00
3 Years Annualised---
5 Years Annualised---
10 Years Annualised---

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The Fund´s investment objective is long-term growth of capital. It pursues its objective by investing in life science equity securities of companies located anywhere in the world and selected for their growth potential.

Portfolio Profile30/09/2016

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
DecreaseAmgen Inc Healthcare3.45
IncreaseEli Lilly and Co Healthcare3.24
IncreasePfizer Inc Healthcare2.96
IncreaseCelgene Corp Healthcare2.76
IncreaseAstraZeneca PLC Healthcare2.67
Asset Allocation %
LongShortNet
Stocks96.240.0096.24
Bonds0.000.000.00
Cash0.000.000.00
Other3.760.003.76
Top Stock Regions
Region%
United States81.02
Eurozone5.82
United Kingdom4.56
Europe - ex Euro4.41
Middle East2.22
Top Stock Sectors
Stock Sector%
Healthcare95.42
Technology3.67
Industrials0.91
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.